Patents by Inventor Emst Boehm

Emst Boehm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant co-expression of vitamin K epoxide reductase subunit 1 to improve vitamin K dependent protein expression
    Publication number: 20060194284
    Abstract: The present invention relates to a host organism containing recombinant nucleic acids coding for the vitamin K reductase complex subunit 1 (VKORC1) and recombinant nucleic acids coding for a vitamin K dependent (VKD) protein, wherein both the recombinant VKORC1 and the recombinant VKD protein are expressed in said host organism. Further, the present invention relates to a cell culture system comprising cells which contain said recombinant nucleic acids and to methods for improving the productivity of recombinant VKD protein expression in a host organism being cultured in suitable systems.
    Type: Application
    Filed: January 27, 2006
    Publication date: August 31, 2006
    Applicants: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Friedrich Scheiflinger, Emst Boehm